SC
Sessa Capital Portfolio holdings
AUM
$3.98B
1-Year Est. Return
26.73%
1 Year Est. Return
+26.73%
AUM
$3.98B
AUM Growth
+$693M
(+21%)
Holding
32
Top Buys
| 1 | +$63.5M | |
| 2 | +$61.2M | |
| 3 | +$56.9M | |
| 4 |
Performance Food Group
PFGC
|
+$31M |
| 5 |
US Foods
USFD
|
+$29.2M |
Top Sells
| 1 | +$45.7M | |
| 2 | +$30.6M | |
| 3 | +$14.8M | |
| 4 |
Illumina
ILMN
|
+$3.43M |
Sector Composition
| 1 | Healthcare | 34.04% |
| 2 | Communication Services | 25.83% |
| 3 | Financials | 14.29% |
| 4 | Utilities | 9.31% |
| 5 | Materials | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Warner Bros
WBD
$73.6B
| $989M | 23.4% |
50,624,148
|
|
||
2
Humana
HUM
$33B
| $576M | 13.63% |
2,212,867
+88,902
|
|
||
|
3
Illumina
ILMN
$20.6B
| $445M | 10.53% |
4,686,779
-36,095
|
|
||
4
Capital One
COF
$152B
| $385M | 9.11% |
1,810,233
|
|
||
5
PG&E
PCG
$33.8B
| $371M | 8.77% |
24,578,101
|
|
||
6
Air Products & Chemicals
APD
$54.5B
| $243M | 5.76% |
891,802
+232,802
|
|
||
7
Ally Financial
ALLY
$13.8B
| $184M | 4.34% |
4,682,126
|
|
||
8
Sotera Health
SHC
$4.77B
| $156M | 3.69% |
9,919,619
+3,619,022
|
|
||
9
Treehouse Foods
THS
$1.21B
| $84.9M | 2.01% |
4,200,000
|
|
||
10
FTAI Aviation
FTAI
$17.5B
| $66.7M | 1.58% |
400,000
|
|
||
11
Zebra Technologies
ZBRA
$13.4B
| $61.5M | 1.46% |
206,984
|
|
||
12
Keurig Dr Pepper
KDP
$39.7B
| $61.2M | 1.45% |
+2,400,000
|
|
||
13
Tandem Diabetes Care
TNDM
$1.5B
| $60.7M | 1.44% |
5,000,000
|
|
||
|
14
US Foods
USFD
$17B
| $59.9M | 1.42% |
781,295
+381,295
|
|
||
|
ASA
15
ASA Gold and Precious Metals
ASA
$1.08B
| $48.1M | 1.14% |
1,050,000
|
|
||
|
GRAL
16
GRAIL Inc
GRAL
$3.55B
| $46.5M | 1.1% |
786,144
|
|
||
17
Roku
ROKU
$16.1B
| $35M | 0.83% |
350,000
|
|
||
18
Fortrea Holdings
FTRE
$1.48B
| $33.6M | 0.8% |
3,993,550
|
|
||
|
19
Performance Food Group
PFGC
$14.8B
| $31M | 0.73% |
+298,147
|
|
||
20
Moderna
MRNA
$11.7B
| $19.2M | 0.45% |
743,081
|
|
||
21
Oscar Health
OSCR
$4.65B
| $9.46M | 0.22% |
500,000
|
|
||
22
SAB Biotherapeutics
SABS
$190M
| $4.42M | 0.1% |
2,198,457
+1,740,000
|
|
||
23
AT&T
T
$172B
| $4.06M | 0.1% |
143,886
|
|
||
24
Lexicon Pharmaceuticals
LXRX
$447M
| $4.05M | 0.1% |
3,000,000
|
|
||
25
Bally's
BALY
$793M
| $1.06M | 0.03% |
95,827
|
|